New Clinical Oncology Study Findings Have Been Reported from Mayo Clinic (Sarcomas Harboring ewsr1::patz1 Fusions: a Clinicopathologic Study of 17 Cases).

A recent study conducted at the Mayo Clinic in Rochester, Minnesota, examined 17 cases of soft tissue sarcomas harboring EWSR1::PATZ1 fusions. The tumors were found in both men and women, with a median age of 50 years. The tumors exhibited various features, including round to spindled cells, fibromyxoid matrix, fibrous bands, and hyalinized vessels. Immunohistochemical analysis showed positive results for markers such as desmin, MyoD1, and S100 protein. The study found that the prognosis for these rare sarcomas may be more favorable than previously reported. Further long-term follow-up is needed to confirm these findings. [Extracted from the article]

Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)